36 related articles for article (PubMed ID: 46254)
1. Two distinct chemotactic factor inactivators in human serum.
Till G; Ward PA
J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil function in infection-prone children.
Håkansson L; Foucard T; Hällgren R; Venge P
Arch Dis Child; 1980 Oct; 55(10):776-81. PubMed ID: 7436443
[TBL] [Abstract][Full Text] [Related]
3. Migration of leukocytes under agarose in the presence of some polymers.
Sýkora J; Stajner A; Palisa V; Krigar V
Folia Microbiol (Praha); 1982; 27(3):214-6. PubMed ID: 7049873
[TBL] [Abstract][Full Text] [Related]
4. Restoration by ketoprofen of defective neutrophil granulocyte migration induced in guinea-pigs by plasma from cancer patients.
Bureau JP; Senelar R; Cupissol D
Br J Exp Pathol; 1980 Oct; 61(5):479-85. PubMed ID: 7004475
[TBL] [Abstract][Full Text] [Related]
5. Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor.
Hanlon SM; Panayi GS; Laurent R
Ann Rheum Dis; 1980 Feb; 39(1):68-74. PubMed ID: 6990882
[TBL] [Abstract][Full Text] [Related]
6. A chemotactic inhibitor in synovial fluid.
Matzner Y; Partridge RE; Babior BM
Immunology; 1983 May; 49(1):131-8. PubMed ID: 6840801
[TBL] [Abstract][Full Text] [Related]
7. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
Hirashima M; Tashiro K; Hayashi H
Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
[TBL] [Abstract][Full Text] [Related]
8. Serum inhibitory effect on myeloperoxidase in human cancer.
Senelar B; Michel R; Tournamille J; Vannereau H; Escola MJ; Taib J; Craste de Paulet A
Br J Exp Pathol; 1982 Jun; 63(3):320-4. PubMed ID: 6284194
[TBL] [Abstract][Full Text] [Related]
9. Transient improvement of polymorphonuclear leukocyte function by splenectomy in beta-thalassemia.
Lianou PE; Bassaris HP; Skoutelis AT; Votta EG; Papavassiliou JT; Phair JP
Med Microbiol Immunol; 1987; 176(4):209-15. PubMed ID: 3614094
[TBL] [Abstract][Full Text] [Related]
10. Release of neutrophil chemotactic factors from gastric tissue. Initial biochemical characterization.
Kozol RA; Downes RJ; Kreutzer DL; Wentzel S; Rossomando E; Elgebaly SA
Dig Dis Sci; 1989 May; 34(5):681-7. PubMed ID: 2653743
[TBL] [Abstract][Full Text] [Related]
11. Studies on the regulation of the neutrophil chemotactic response using a rapid and reliable method for measuring random migration and chemotaxis of neutrophil granulocytes.
Keller HU; Gerber H; Hess MW; Cottier H
Agents Actions; 1976 Feb; 6(1-3):326-39. PubMed ID: 782208
[TBL] [Abstract][Full Text] [Related]
12. Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition.
Epps DE; Williams RC
Infect Immun; 1976 Mar; 13(3):741-9. PubMed ID: 773824
[TBL] [Abstract][Full Text] [Related]
13. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
Orr W; Varani J; Ward PA
Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
[TBL] [Abstract][Full Text] [Related]
15. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
Goldblum SE; Van Epps DE; Reed WP
J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
[TBL] [Abstract][Full Text] [Related]
16. Antileukotactic properties of tumor cells.
Brozna JP; Ward PA
J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.
Clark RA; Klebanoff SJ
J Clin Invest; 1979 Oct; 64(4):913-20. PubMed ID: 225353
[TBL] [Abstract][Full Text] [Related]
18. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma.
Meakins JL; Pietsch JB; Bubenick O; Kelly R; Rode H; Gordon J; MacLean LD
Ann Surg; 1977 Sep; 186(3):241-50. PubMed ID: 142452
[TBL] [Abstract][Full Text] [Related]
19. Regulatory dysfunction in leukotaxis.
Ward PA; Johnson KJ; Kreutzer DL
Am J Pathol; 1977 Sep; 88(3):701-10. PubMed ID: 142429
[TBL] [Abstract][Full Text] [Related]
20. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
Johnson KJ; Anderson TP; Ward PA
J Clin Invest; 1977 May; 59(5):951-8. PubMed ID: 140184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
